These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3607801)

  • 1. [Creatine phosphate: an additive to cardioplegic solutions. Clinical study].
    D'Alessandro LC; Cini R; Stazi G; Pucci A; De Benedictis F; Rabitti G; Benhar M; Giacopino F; Pezza E; Cioli G
    Cardiologia; 1987 Mar; 32(3):307-13. PubMed ID: 3607801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method].
    Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

  • 4. Creatine phosphate: a critical variable in assessing metabolic activity during cardioplegic arrest.
    Ellis RJ; Gardner CP
    Surg Forum; 1979; 30():243-5. PubMed ID: 538609
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic enhancement of myocardial preservation during cardioplegic arrest.
    Rousou JA; Engelman RM; Anisimowicz L; Lemeshow S; Dobbs WA; Breyer RH; Das DK
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):270-6. PubMed ID: 3945094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of myocardial high energy phosphates by induction of ventricular fibrillation prior to cardioplegic arrest.
    Levett JM; Kadowaki MH; Ip JH; Karp RB
    J Cardiovasc Surg (Torino); 1990; 31(2):209-12. PubMed ID: 2341480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
    Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
    Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and functional effects of creatine phosphate in cardioplegic solution. Studies on rat hearts during and after normothermic ischemia.
    Thelin S; Hultman J; Ronquist G; Hansson HE
    Scand J Thorac Cardiovasc Surg; 1987; 21(1):39-45. PubMed ID: 3589594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Feb; 87(2):190-200. PubMed ID: 6694410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-induced ventricular contraction during cardioplegic arrest.
    Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioplegic arrest in pigs. Effects of glucose-containing solutions.
    Salerno TA; Chiong MA
    J Thorac Cardiovasc Surg; 1980 Dec; 80(6):929-33. PubMed ID: 7431990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of myocardial high-energy phosphates during cardioplegic arrest with nifedipine.
    Kadowaki MH; Levett JM; Ip JH; Karp RB
    Curr Surg; 1987; 44(4):298-9. PubMed ID: 3665578
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The superiority of blood cardioplegia in myocardial preservation.
    Engelman RM; Rousou JH; Dobbs W; Pels MA; Longo F
    Circulation; 1980 Aug; 62(2 Pt 2):I62-6. PubMed ID: 7397998
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of crystalloid cardioplegic solutions in patients undergoing myocardial revascularization. Effect of infusion route and regional wall motion on preservation of adenine nucleotide stores.
    Silverman NA; Wright R; Levitsky S; Schmitt G; Feinberg H
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):90-6. PubMed ID: 3965820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of crystalloid and sanguineous cardioplegic solutions in the dog.
    Spackman CJ; Caywood DD; Gannon PG; Irmiter RA; Louis CF
    Am J Vet Res; 1985 Jun; 46(6):1330-4. PubMed ID: 4026010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):39-43. PubMed ID: 7350387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ionic bases of cardioplegic solutions. I. Some implications of the role of ionic equilibrium in the preservation of cardiac metabolism. Experimental study of hypoxia and calcium overloads].
    Ventura-Clapier R; Vassort G
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1456-64. PubMed ID: 6322714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.